Continental Advisors LLC Bausch Health Companies Inc. Transaction History

Continental Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$7.06 - $23.63 $162,380 - $543,490	-23,000 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$21.37 - $34.38 $1.64 Million - $2.63 Million	-76,576 Reduced 76.9%	23,000 $730,000
Q3 2020 Nov 16, 2020	BUY	$14.88 - $20.13 $431,520 - $583,770	29,000 Added 41.09%	99,576 $1.55 Million
Q4 2019 Feb 10, 2020	SELL	$18.89 - $31.89 $164,777 - $278,176	-8,723 Reduced 11.0%	70,576 $2.11 Million
Q1 2019 May 14, 2019	SELL	$20.23 - $26.29 $1.4 Million - $1.82 Million	-69,125 Reduced 46.57%	79,299 $1.96 Million

Q4 2018 Feb 14, 2019	SELL	$17.64 - $28.32 $176,400 - $283,200	-10,000 Reduced 6.31%	148,424 $2.74 Million
Q3 2018 Nov 14, 2018	BUY	$20.64 - $25.67 $3.27 Million - $4.07 Million	158,424 New	158,424 $4.07 Million

281

278M

21.5M

21.8M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.57B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Continental Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Continental Advisors LLC with notifications on news.